×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [3]
Authors
TAM KIN YIP [3]
Document Type
Journal article [3]
Date Issued
2013 [3]
Language
英語English [3]
Source Publication
ADMET & DMPK [3]
Indexed By
ESCI [3]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-3 of 3
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Journal Impact Factor Ascending
Journal Impact Factor Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Issue Date Ascending
Issue Date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
The roles of doxorubicin in hepatocellular carcinoma
Journal article
Kin Tam. The roles of doxorubicin in hepatocellular carcinoma[J]. ADMET & DMPK, 2013, 1(3), 29-44.
Authors:
Kin Tam
Favorite
|
TC[WOS]:
25
TC[Scopus]:
29
IF:
3.4
/
2.8
|
Submit date:2019/01/07
Primary Liver Cancer
Anticancer
Cytotoxic Drug
Transarterial Chemoembolization
Drug Eluting Beads
One year in circulation – an exciting journey for ADMET & DMPK
Journal article
Kin Tam. One year in circulation – an exciting journey for ADMET & DMPK[J]. ADMET & DMPK, 2013, 1(4), 46-47.
Authors:
Kin Tam
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
3.4
/
2.8
|
Submit date:2019/01/07
Estimating the “First in human” dose – a revisit with particular emphasis on oncology drugs
Journal article
Kin Tam. Estimating the “First in human” dose – a revisit with particular emphasis on oncology drugs[J]. ADMET & DMPK, 2013, 1(4), 63-75.
Authors:
Kin Tam
Favorite
|
TC[WOS]:
14
TC[Scopus]:
15
IF:
3.4
/
2.8
|
Submit date:2019/01/07
Initial Dose
Starting Dose
Clinical Trial
Noael
Mabel
Cytotoxic
Anticancer
Combination Therapy Study